News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Mike Thompson: Myeloma/Plasma Cell Dyscrasia – Top Abstract Highlights from ASH24
Mike Thompson/LinkedIn
Nov 21, 2024, 16:11

Mike Thompson: Myeloma/Plasma Cell Dyscrasia – Top Abstract Highlights from ASH24

Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:

 “Myeloma/Plasma Cell Dyscrasia ~ ASH24Top10 (or so) Multiple Myeloma ASH24 by Mike Thompson

*DRAFT* Table Update: Nov 20, 2024″

Mike Thompson: Myeloma/Plasma Cell Dyscrasia - Top Abstract Highlights from ASH24

 

ASH24 cancer Cell Dyscrasia Joseph Mikhael Mike Thompson multiple myeloma Myeloma OncoDaily Oncology Samer Al Hadidi Tempus
Special Coverage
Blog
Jan 23, 2025, 21:19
Boris Pasche: A Memorable Day for Karmanos Cancer Institute
Blog
Jan 23, 2025, 21:19
Susanna Fletcher Greer: Outsmarting Kidney Cancer with a New Triple Therapy Approach
Blog
Jan 23, 2025, 21:18
Cathy Eng: Cancer is indifferent to politics and impacts everyone
Blog
Jan 23, 2025, 21:18
Nicholas P. Restifo: A Groundbreaking Discovery in Cancer Immunotherapy
Blog
Jan 23, 2025, 21:18
Nick Grant: A Bold and Collaborative Programme for Cancer Prevention
Blog
Jan 23, 2025, 21:18
Alexandre Chan: The HERBAL Trial and Its Impact on Integrative Oncology
Blog
Jan 23, 2025, 21:18
Toufic Kachaamy: Call for Papers on Gastrointestinal Oncology
Blog
Jan 23, 2025, 21:18
Lisa A. Lacasse: The American Cancer Society Is Here for Those Impacted by the LA Fires
Blog
Jan 23, 2025, 21:18
Interview with Dr. William Pao on Groundbreaking Contributions to Cancer Research - SPCC
Blog
Jan 23, 2025, 21:18
Become The Second Global OncoThon Changemaker - SIOP
Drugs
Jan 23, 2025, 20:48
New guideline update on Neoadjuvant Chemotherapy for Ovarian Cancer - ASCO
Blog
Jan 23, 2025, 20:48
Carolyn Taylor: Honored to participate in the Lancet Global Health Commission on People-Centered Care for Universal Health Coverage